Intelligence Platform
Pipeline programs
Browse 12,558 clinical pipeline programs from ClinicalTrials.gov, linked to pharma companies. Phase, modality, and trial IDs for BD teams.
Imiquimod
UNITED THERAPEUTICS Corp
1 trials projectImiquimod Cream, 3.75%
TEVA PHARMACEUTICAL INDUSTRIES LTD
1 trials projectImmune Globulin 10% Intravenous Solution
Vera Therapeutics
1 trials projectImmune Globulin Infusion (Human), 10%
TAKEDA PHARMACEUTICAL CO LTD
1 trials projectImmune Globulin Intravenous (Human), 10%
TAKEDA PHARMACEUTICAL CO LTD
2 trials projectImmune Globulin Intravenous (Human), 10% (IGIV, 10%)
TAKEDA PHARMACEUTICAL CO LTD
1 trials projectImmune Globulin Intravenous (Human), 10% (IGIV, 10%) 400 mg/kg
TAKEDA PHARMACEUTICAL CO LTD
1 trials projectImmune Globulin Intravenous (Human), 10% Solution
TAKEDA PHARMACEUTICAL CO LTD
1 trials projectImmune Globulin Intravenous (Human), 10% Solution
TAKEDA PHARMACEUTICAL CO LTD
1 trials projectImmune Globulin Intravenous (IGIV)
TAKEDA PHARMACEUTICAL CO LTD
1 trials projectImmune Globulin Intravenous (human), 10%
TAKEDA PHARMACEUTICAL CO LTD
1 trials projectImmune Globulin Subcutaneous (Human), 20%
TAKEDA PHARMACEUTICAL CO LTD
1 trials projectImmunoglobulins, Intravenous (Privigen)
UNITED THERAPEUTICS Corp
1 trials projectImmunonutrition ๏ผSu yusu)
China SXT Pharmaceuticals
1 trials projectIn-person Cognitive Behavioral Therapy of Insomnia
UNITED THERAPEUTICS Corp
1 trials projectInactivated Poliomyelitis Vaccine (Sabin strains)
China SXT Pharmaceuticals
2 trials projectIncobotulinumtoxinA (XEOMINยฎ)
Camp4 Therapeutics Corp
1 trials projectIndiplon
NEUROCRINE BIOSCIENCES INC
1 trials projectIndividualized Elective Neck Irradiation
China SXT Pharmaceuticals
1 trials projectInduction Chemotherapy
First Tracks Biotherapeutics
1 trials projectInfacortยฎ
NEUROCRINE BIOSCIENCES INC
4 trials projectInfigratinib
BridgeBio Oncology Therapeutics
1 trials projectInfigratinib 0.25 mg/kg/day
BridgeBio Oncology Therapeutics
1 trials projectInfliximab + methotrexate (IFX + MTX)
INTEGRATED BIOPHARMA INC
1 trials